Table 1 Summary of the patient data, measurement results, and statistical comparisons
P | ||||
---|---|---|---|---|
total | Group A | Group B | Group A vs B | |
No. of eyelids/patients | 66/40 | 26/16 | 40/24 | — |
No. of patients bilateral/unilateral | 26/14 | 10/6 | 16/8 | 0.525a |
Right/left | 34/32 | 13/13 | 22/18 | 0.953a |
Male/female | 14/26 | 8/8 | 6/18 | 0.542a |
Age (range), yrs | 70.6±9.4 (47 to 87) | 68.5±9.0 (54 to 87) | 70.8±9.1 (47 to 87) | 0.589b |
Levator function (range), mm | 13.8±4.5 (6.5 to 16) | 13.2±4.5 (8.0 to 15.5) | 13.9±4.6 (6.5 to 16) | 0.835b |
Volume of anaesthetics (range), mm | 0.75±0.28 (0.6 to 1.6) | 0.80±0.35 (0.6 to 1.5) | 0.73±0.25 (0.7 to 1.6) | 0.899b |
Preoperative MRD-1 (range), mm | 0.06±0.81 (−2.0 to 2.5) | 0.09±1.17 (−1.5 to 2.5) | 0.04±0.58 (−2.0 to 2.0) | 0.669b |
MRD-1 using phenylephrine eye drop | 0.55±1.01 (−2.0 to 3.0) | 1.22±1.21 (−0.5 to 3.0) | 0.04±0.58 (−2.0 to 2.0) | <0.001c |
Intraoperative MRD-1 (range), mm | 2.46±1.11 (2.0 to 4.5) | 2.80±0.79 (2.0 to 4.5) | 2.30±1.03 (2.0 to 4.0) | 0.225b |
Postoperative 3-month MRD-1 (range), mm | 2.12±1.0 (0 to 4.5) | 2.12±1.05 (0 to 4.5) | 2.13±1.01 (0.5 to 4.0) | 0.915b |
ΔMRD-1 (range), mm | 0.34±0.55 (0 to 2.0) | 0.68±0.52 (0 to 2.0) | 0.17±0.56 (0 to 1.5) | 0.004c |
P-value: intra vs post 3-month MRD-1 | <0.001d | <0.001d | 0.045d | — |